SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019768
Filing Date
2023-05-09
Accepted
2023-05-09 16:34:16
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rxdx-20230331.htm   iXBRL 10-Q 2254386
2 EX-31.1 rxdx-ex31_1.htm EX-31 21815
3 EX-31.2 rxdx-ex31_2.htm EX-31 21248
4 EX-32.1 rxdx-ex32_1.htm EX-32 13982
5 EX-32.2 rxdx-ex32_2.htm EX-32 13449
  Complete submission text file 0000950170-23-019768.txt   9812519

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxdx-20230331_def.xml EX-101.DEF 208885
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxdx-20230331_cal.xml EX-101.CAL 51568
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxdx-20230331.xsd EX-101.SCH 58831
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxdx-20230331_lab.xml EX-101.LAB 496410
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxdx-20230331_pre.xml EX-101.PRE 370634
64 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-20230331_htm.xml XML 2211001
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40187 | Film No.: 23902730
SIC: 2834 Pharmaceutical Preparations